A Unique Needle-Free Delivery System for Injectable, Precision Engineered, Thermally Stable, Unit Solid Dose Vaccines

David Grant is the Head of Device Development at Enesi Pharma Ltd, leading the development of its needle-free delivery technologies for the administration of room-temperature stable, solid-dose, vaccines as part of Enesi’s ImplaVax® vaccination technology – designed to deliver immunity irrespective of target, disease, geography or socioeconomic class. Since studying Physics at the University of Cambridge, UK, David has 15 years’ of experience of working with game-changing technologies and over 10 years’ experience in the field of injectables, conducting extensive research into the injection dynamics of solid doses.